Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Seminars in Thrombosis and Hemostasis|January 1, 1991
Experimental and clinical validation of the prophylactic antithrombotic effects of a low molecular weight heparin (enoxaparin)J Fareed, J M Walenga, D Hoppensteadt, et al.
Thrombosis Research|March 15, 1996
Poor correlation between soluble fibrin concentrations measured by two commercially available immunoassaysH B Rahr, D Danielsen, B S Andersen, et al.
International Journal of Clinical Pharmacology and Therapeutics|May 1, 1994
Perioperative thrombosis prophylaxis with low molecular weight heparins in elective hip surgery. Clinical and economic considerationsL C Borris, M R Lassen, H P Jensen, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 24, 1999
Clinical limitations of risk assessment modelsM R Lassen, L C Borris, S Backs, et al.
Seminars in Thrombosis and Hemostasis|November 5, 1999
Deep-vein thrombosis prophylaxis in orthopedic surgery: hip surgeryM R Lassen, S Backs, L C Borris, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 1990
Levels of thrombin--antithrombin-III complex and factor VIII activity in relation to post-operative deep vein thrombosis and influence of prophylaxis with a low-molecular-weight heparinJ V Sørensen, L C Borris, M R Lassen, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Dose relation in the prevention of proximal vein thrombosis with a low molecular weight heparin (tinzaparin) in elective hip arthroplastyM R Lassen, L C Borris, H P Jensen, et al.
Thrombosis Research|March 1, 1992
Markers of coagulation and fibrinolysis after fractures of the lower extremitiesJ V Sørensen, H B Rahr, H P Jensen, et al.
Pageof 7